Display options
Cite
Kho MML, Reinders MEJ, Baan CC, et al. The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis, or living with a kidney transplant - a prospective, controlled, multicenter observational cohort by the REnal patients COVID-19 VACcination (RECOVAC) consortium COVID-19 VACcination (RECOVAC) consortium. Nephrol Dial Transplant. 2021;doi: 10.1093/ndt/gfab186.
Kho, M. M. L., Reinders, M. E. J., Baan, C. C., van Baarle, D., Bemelman, F. J., Diavatopoulos, D. A., Gansevoort, R. T., van der Klis, F. R. M., Koopmans, M. P. G., Messchendorp, A. L., van der Molen, R. G., Remmerswaal, E. B. M., Rots, N., Vart, P., de Vries, R. D., Hilbrands, L. B., Sanders, J. F. (2021). The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis, or living with a kidney transplant - a prospective, controlled, multicenter observational cohort by the REnal patients COVID-19 VACcination (RECOVAC) consortium COVID-19 VACcination (RECOVAC) consortium. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, . https://doi.org/10.1093/ndt/gfab186
Kho, Marcia M L, et al. "The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis, or living with a kidney transplant - a prospective, controlled, multicenter observational cohort by the REnal patients COVID-19 VACcination (RECOVAC) consortium COVID-19 VACcination (RECOVAC) consortium." Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association vol. (2021). doi: https://doi.org/10.1093/ndt/gfab186
Kho MML, Reinders MEJ, Baan CC, van Baarle D, Bemelman FJ, Diavatopoulos DA, Gansevoort RT, van der Klis FRM, Koopmans MPG, Messchendorp AL, van der Molen RG, Remmerswaal EBM, Rots N, Vart P, de Vries RD, Hilbrands LB, Sanders JF. The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis, or living with a kidney transplant - a prospective, controlled, multicenter observational cohort by the REnal patients COVID-19 VACcination (RECOVAC) consortium COVID-19 VACcination (RECOVAC) consortium. Nephrol Dial Transplant. 2021 May 26; doi: 10.1093/ndt/gfab186. Epub 2021 May 26. PMID: 34038554.
Copy Download .nbib Format: NLM
Share it on

Nephrol Dial Transplant. 2021 May 26; doi: 10.1093/ndt/gfab186. Epub 2021 May 26.

The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis, or living with a kidney transplant - a prospective, controlled, multicenter observational cohort by the REnal patients COVID-19 VACcination (RECOVAC) consortium COVID-19 VACcination (RECOVAC) consortium.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Marcia M L Kho, Marlies E J Reinders, Carla C Baan, Debbie van Baarle, Frederike J Bemelman, Dimitri A Diavatopoulos, Ron T Gansevoort, Fiona R M van der Klis, Marion P G Koopmans, A Lianne Messchendorp, Renate G van der Molen, Ester B M Remmerswaal, Nynke Rots, Priya Vart, Rory D de Vries, Luuk B Hilbrands, Jan-Stephan F Sanders,

Affiliations

  1. Erasmus MC Transplant Institute, Department of Internal Medicine, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  2. Department of Medical Microbiology and Infectionprevention, University Medical Center Groningen, Groningen, The Netherlands.
  3. Center for infectious diseases control (CiB), National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
  4. Renal Transplant Unit, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  5. Radboud Institute for Molecular Life Sciences; Department of Laboratory Medicine, Laboratory of Medical Immunology, section Pediatric Infectious Diseases; Radboud Center for Infectious Diseases, Radboud University Nijmegen Medical Center, The Netherlands.
  6. Department of Internal Medicine, Division of Nephrology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  7. Department Viroscience, Erasmus MC, Rotterdam, the Netherlands.
  8. Radboud Institute for Molecular Life Sciences, Department of Laboratory Medicine, Laboratory of Medical Immunology, Radboud University Medical Center, Nijmegen, The Netherlands.
  9. Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  10. Department of Health Evidence, Radboud university medical center, Radboud University, Nijmegen, The Netherlands.
  11. Department of Cardiology, Radboud University Medical Center, Radboud University, Nijmegen, The Netherlands.
  12. Department of Nephrology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.

PMID: 34038554 DOI: 10.1093/ndt/gfab186

[No abstract available.]

Publication Types